A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma
Clinical trial NCT06642961 · UNKNOWN
Trial details
- NCT number
- NCT06642961
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2025-03-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.